We are live on ! Find out more
SC

Samjo Capital Portfolio holdings

AUM $254M
1-Year Est. Return 36.81%
This Fund
S&P 500
This Quarter Est. Return
+27.37%
1 Year Est. Return
+36.81%
3 Year Est. Return
+89.15%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
+$17.6M
Cap. Flow
-$3.12M
Cap. Flow %
-2.31%
Top 10 Hldgs %
84.16%
Holding
22
New
4
Increased
7
Reduced
4
Closed
2

Top Buys

Rank Stock Value
1
LAB icon
Standard BioTools
LAB
+$4.48M
2
SCOR icon
Comscore
SCOR
+$4.3M
3
PDFS icon
PDF Solutions
PDFS
+$3.88M
4
XGN icon
Exagen
XGN
+$2.67M
5
SHSP
SharpSpring, Inc.
SHSP
+$2.07M

Top Sells

Rank Stock Value
1
GAN
GAN Ltd
GAN
+$9M
2
GNMK
GenMark Diagnostics, Inc
GNMK
+$7.74M
3
NEO icon
NeoGenomics
NEO
+$3.77M
4
ASPN icon
Aspen Aerogels
ASPN
+$1.85M
5
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
+$1.67M

Sector Composition

Rank Sector Weight
1 Communication Services 35.84%
2 Technology 33.32%
3 Healthcare 10.3%
4 Industrials 6.81%
5 Consumer Discretionary 3.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QUOT
1
DELISTED
Quotient Technology Inc
QUOT
$39.2M 29.09%
2,400,000
-85,000
-3% -$1.05M
PDFS icon
2
PDF Solutions
PDFS
$2.17B
$21.6M 16.04%
1,216,000
+196,000
+19% +$3.88M
INOV
3
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$11.4M 8.43%
395,000
-65,000
-14% -$1.67M
VG
4
DELISTED
Vonage Holdings Corporation
VG
$9.1M 6.75%
770,000
+130,000
+20% +$1.69M
ITI
5
DELISTED
Iteris, Inc.
ITI
$7.96M 5.9%
1,290,000
+25,000
+2% +$160K
ASPN icon
6
Aspen Aerogels
ASPN
$419M
$7.02M 5.21%
345,000
-87,657
-20% -$1.85M
GAN
7
DELISTED
GAN Ltd
GAN
$5.37M 3.98%
295,000
-355,000
-55% -$9M
SCOR icon
8
Comscore
SCOR
$112M
$4.46M 3.31%
+61,000
New +$4.3M
LAB icon
9
Standard BioTools
LAB
$336M
$3.68M 2.73%
+815,000
New +$4.48M
NEPH icon
10
Nephros
NEPH
$40.8M
$3.66M 2.71%
550,000
– –
RSSS icon
11
Research Solutions
RSSS
$73.6M
$3.39M 2.51%
1,460,000
+660,000
+83% +$1.56M
THRY icon
12
Thryv Holdings
THRY
$186M
$2.69M 2%
115,000
+15,000
+15% +$303K
SHSP
13
DELISTED
SharpSpring, Inc.
SHSP
$2.64M 1.96%
165,000
+104,000
+170% +$2.07M
XGN icon
14
Exagen
XGN
$103M
$2.63M 1.95%
+150,000
New +$2.67M
HTGM
15
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$2.35M 1.74%
35,833
+4,024
+13% +$305K
FRG
16
DELISTED
Franchise Group, Inc.
FRG
$2.17M 1.61%
60,000
– –
SCTL
17
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$1.56M 1.16%
+560,000
New +$2.01M
TACT icon
18
Transact Technologies
TACT
$53.2M
$1.41M 1.05%
130,000
– –
DMRC icon
19
Digimarc Corp
DMRC
$137M
$742K 0.55%
25,000
– –
NEO icon
20
NeoGenomics
NEO
$1.93B
– –
-70,000
Closed -$3.77M
GNMK
21
DELISTED
GenMark Diagnostics, Inc
GNMK
– –
-530,000
Closed -$7.74M

Similar funds

T
TRUADVICE Sarasota, Florida $255M AUM 14.45% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
RBGI
Ribbit Bullfrog GP II Palo Alto, California $258M AUM 33.43% 1-Year Est. Return
IAM
Innovis Asset Management Chicago, Illinois $260M AUM 28.13% 1-Year Est. Return
RCGI
Ribbit Capital GP II Palo Alto, California $260M AUM 2.87% 1-Year Est. Return
W
WealthOne Albany, New York $248M AUM 17.79% 1-Year Est. Return
AEPLI
AH Equity Partners LSV III Menlo Park, California $262M AUM 59.24% 1-Year Est. Return
PWM
PRW Wealth Management Quincy, Massachusetts $262M AUM 22.64% 1-Year Est. Return

Samjo Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Samjo Capital held 22 positions worth $135M, up 15% from $117M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

Samjo Capital's Q1 2021 filing shows 4 new, 7 increased, 4 reduced and 2 closed positions. Its largest new stake was Standard BioTools: 815,000 shares worth $3.68M. The largest sale was GAN Ltd, an estimated $9M.

By sector, the portfolio is most concentrated in Communication Services at 36% of assets, up from 27% a quarter earlier, followed by Technology and Healthcare.

  • Samjo Capital's largest Q1 2021 buy was Standard BioTools: 815,000 shares worth $3.68M.
  • Samjo Capital added most to PDF Solutions in Q1 2021, an estimated $3.88M increase.
  • Samjo Capital's biggest Q1 2021 reduction was GAN Ltd, cutting an estimated $9M.
  • Samjo Capital fully exited GenMark Diagnostics, Inc in Q1 2021, selling an estimated $7.74M.
  • Samjo Capital's ten largest holdings make up 84% of its $135M portfolio in Q1 2021.
  • Samjo Capital opened 4 new positions and closed 2 in Q1 2021.
  • Samjo Capital's portfolio value rose 15% quarter-over-quarter to $135M.

Based on Samjo Capital's 13F filing for Q1 2021, filed 12 May 2021.